Cellular Pathology
 

Chapter 4. Tissue Repair: Cellular Growth,
        Fibrosis, and Wound Healing

ÇнÀ¸ñÀû  ¼¼Æ÷ÀÇ ½ÅÈ£Àü´Þü°è¸¦ ÀÌÇØÇÔÀ¸·Î½á ¼¼Æ÷ÀÇ È°µ¿ÀÌ ¾î¶»°Ô Á¶ÀýµÇ´ÂÁö¸¦ ¾Ë°í, ½ÅÈ£Àü´Þü°è°¡ Àß ¸ø µÇ¾úÀ» ¶§ ¾î¶² ÀÏÀÌ ¹ú¾îÁú ¼ö Àִ°¡¸¦ »ý°¢Çϸç, Ä¡À¯¿Í ¼öº¹°úÁ¤À» ÀÌÇØÇÑ´Ù.

CONTROL OF NORMAL CELL GROWTH

Cell Cycle and Proliferative Potential

 

 - Labile Cells

     : Continuously dividing cells

ü¼¼Æ÷¸¦ Àç»ý´É·Â¿¡ µû¶ó ºÐ·ùÇϰí, ±× Ư¼ºÀ» ¼³¸íÇÑ´Ù. (A)

     : Surface epithelia; Squamous, columnar,
                          transitional
       Hematopoietic, lymphoid, splenic tissue

 

  - Stable cells

      : Quiescent cells, dividing by stimulation

      : Parenchymal cells of glandular organs;
          
Liver, kidney, pancreas
        Mesenchymal cells;
 
          Fibroblasts, endothelial cells, smooth muscle cells,            chondroblasts, osteoblasts,

    : The underlying framework of the parenchymal
      cells, mainly the basement membrane, is
      necessary for organized regeneration

regeneration re- + L. generare to produce, bring to life

  - Permanent cells

      : Nondividing cells in postnatal life

      : Nerve cells
        Skeletal and cardiac muscle cells, practically

 


 

Cell populations and cell cycle phases.

Constantly dividing labile cells continuously cycle from one mitosis to the next. Nondividing permanent cells have exited the cycle and are destined to die without further division. Quiescent stable cells in G0 are neither cycling nor dying and can be induced to re-enter the cell cycle by an appropriate stimulus.


Molecular Events in Cell Growth - Biosignaling


 

Cell Signaling

Plasma membrane receptorÀÇ Á¾·ù¸¦ ¿­°ÅÇÑ´Ù. (A)


          Plasma membrane receptors

            0. Ligand-gated ion channels
            1. Receptor enzymes
                 (1) TK receptors (
Receptors with intrinsic kinase activity)
                 (2) Serine-threonine kinase receptor
                 (3) Guanylyl cyclase receptors
            2. Receptor non-enzymes (
Cytokine receptor superfamily)
                 (1) JAK/STAT system 
            3. G protein-linked receptors (Seven-spanning receptors,
                                           Serpentine receptors)

 

 <Signal Transduction Pathway>

    I. Ligand-receptor binding, membranous

   II. Activation of receptors

  III. Signal transduction and second messengers

         1. Receptor enzymes

signal transduction pathwayÀÇ °úÁ¤À» ¼³¸íÇÑ´Ù. (A)
G proteins = Guanine nucleotide-binding) proteins) with intrinsic GTPase activity

- Monomeric G
  proteins (ras)
- Heterotrimeric G
  proteins (G¥á¥â¥ã)

               (1) TK receptors (Receptors with intrinsic kinase activity) -
                   InsulinR, EGFR
(c-erb B1), PDGFR, FGFR, VEGFR,AngiopoietinR

                     (a) MAP kinase pathway (ras pathway)
                     (b) PI-3-kinase pathway
                         (Phosphoinositide-3-kinase pathway)

                     (c) IP3 pathway (Phospholipase C (PLC¥ã) pathway)
 
                          : PLC¥ã = IP3 - Ca++ - Ca++-binding proteins¡è
                                   = DAG - PKC
¡è
                                    (Tumor promoter: Phorbol esters)
                     (d) src family pathway (with tyrosine kinase activity) 

               (2) Serine-threonine kinase receptor

                     (a) TGF¥â receptor

               (3) Guanylyl cyclase receptors

                     (a) ANP receptor, guanylin receptor
                     (b) NO receptor

           2. Receptor non-enzymes (Cytokine receptor superfamily)

                (1) JAK/STAT system: Cytokine receptors, leptin receptor

           3. G protein-linked receptors (Seven-spanning receptors,
                                          Serpentine receptors)

                : Heterotrimeric G proteins (G¥á¥â¥ã)

                (1) cAMP pathway

                      - ¥â-Adrenergic R., glucagon R., chemokine Rs.
                          : G
s - Adenylate cyclase - cAMP - PKA¡è
                      - Somatostatin R.
                          : G
i - Adenylate cyclase¡é - cAMP¡é - PKA¡é
                      - Gustatory R.
                          : G
gust - Adenylate cyclase - cAMP - PKA¡è - PK+¡é
                           (gustducin)                       (depolarization)
                      - Olfactory R.
                          : G
olf - Adenylate cyclase - cAMP - PCa++, Na+¡è
                                                             (depolarization)

                    cGMP pathway

                      - Photoreceptor (rhodopsin)
                          : Transducin - Phosphodiesterase-cGMP¡é-
PCa++, Na+¡é
                                                          (hyperpolarization)

                (2) IP3 pathway (Phospholipase C (PLC¥â) pathway)

                      - Olfactory R.
                          : G
olf - PLC¥â - IP3 - PCa++¡è (depolarization)
                      - Chemokine Rs.,
                        Acetylcholine [muscarinic M1] R.,
                        ¥á1-adrenergic agonist R.

                          : Gq
- PLC¥â = IP3 - Ca++ - Ca++-binding proteins¡è
                                       = DAG - PKC
¡è
                                        (Tumor promoter: Phorbol esters)

    IV. Transcription factors

          1. Early response genes

              : c-fos, c-jun, c-myc

          2. Late response genes

     *. Phosphatases

          : Phosphatase inhibitor - Tumor promoter: Okadoic acid

Signaling from activated tyrosine kinase receptors
 

    (a) MAP-kinase pathway (ras pathway)      Binding of a growth factor causes the receptor to dimerize and cross-phosphorylate tyrosine residues. Binding of adapter (or bridging) proteins (e.g. GRB2 and SOS) couple the receptor with inactive Ras. Cycling of Ras between its inactive and active forms is regulated by GAP. Activated Ras interacts with and activates Raf-1. This kinase then phosphorylates a component of the MAPK signaling pathway, MEK, which then phosphorylates MAPK (ERK). Activated MAPK phosphorylates other cytoplasmic proteins and nuclear transcription factors generating cellular responses. The phosphorylated tyrosine kinase receptor can also bind other components, such as PI-3 kinase, which activates distinct signaling systems.

    (b) PI-3-kinase pathway
        (Phosphoinositide-3-kinase pathway)

      Ligand - Tyrosine kinase receptor ¡æ

      PI-3-K (PI3-kinase = Phosphoinositide-3-kinase) ¡æ

      PIP2 (phosphatidyl inositol bisphosphate) ¡æ
      PIP
    3 (phosphatidyl inositol trisphosphate) ¡æ

      PKB (protein kinase B) ¡æ

      Phosphorylation of target proteins

    (c) IP3 pathway
        (Phospholipase C (PLC¥ã) pathway)

         Vide infra (Phospholipase C (PLC¥â) pathway)

    (d) src family pathway,
        with tyrosine kinase activity

ras pathway¸¦ ±×¸²À¸·Î ¼³¸íÇÑ´Ù. (A)

GRB2 = Growth factor Receptor Binding protein 2 with SH2 domain (Src Homology domain 2)
(
Src = encoded by src gene of avian sarcoma virus)

SOS = son of sevenless = GNRP = Guanine nucleotide releasing protein

ras = rat sarcoma virus

GAPs = GTPase activating proteins

Raf-1 = Ras-activated factor 1

MEK = MAPK/ERK activating kinase

MAPK = Mitogen-Activated Protein Kinase = ERK (Extracellular signal-Regulated Kinase)

inositol G. is, (gen,) inos fiber, muscle finer, sinew + ISV -ite + -ol

PI-3-kinase pathway¸¦ ¼³¸íÇÑ´Ù. (A)

PI-3-kinase = phospho-
inositide-3-kinase

PIP2 = phosphatidyl inositol 4,5-bisphosphate

PIP3 = phosphatidyl inositol 3,4,5-trisphosphate

PLC¥ã
    Phospholipase C¥ã,
    
with SH2 domain,
    activated by
    tyrosine kinase
    receptors

DAG = 1,2-diacyl glycerol

IP3 = inositol 1,4,5-trisphosphate

PKC Ca++-dependent
    protein kinase

 

    * SOS (son of sevenless) = GNRP (Guanine nucleotide
    releasing protein).

       The eye of Drosphila is composed of about 800 identical units, each having a separate lens that focuses light onto eight photoreceptor cells at its base. R7 is the last photoreceptor cell to develop, required for the detection of UV light. A mutant fly with R7 defect is called sevenless (sev), and the gene sev. The sev gene is a receptor tyrosine kinase and requires a second gene, son-of sevenless (sos), to activate Ras. The sos gene encodes GNRP.

SEM of a compound eye of Drosophila.


Signaling from activated receptor non-enzymes
 

 

    JAK/STAT system by which the leptin signal is transduced in the hypothalamus. Leptin binding induces dimerization of the leptin receptor, followed by phosphorylation of Tyr residues of the receptor, catalyzed by JAK. STATs that bind to the phosphorylated leptin ceceptor are then phosphorylated on Tyr residues by a separate activity of JAK. The STATs dimerize, binding each other's phosphorylated Tyr residues, and enter the nucleus, where they bind specific regulatory regions in the DNA and alter expression of specific genes. The products of these genes ultimately influence feeding behavior and energy expenditure.

JAK/STAT systemÀ» ±×¸²À¸·Î ¼³¸íÇÑ´Ù. (A)

JAKs = Janus kinases

STATs = signal transducers and activators of transcription


Signaling from activated guanylyl cyclase receptors
 

 
      (a)            (b)

    Two types (isozymes) of guanylyl cyclase involved in signal transduction.

    (a) ANF receptor, guanylin receptor

         The first type exists in two similar membrane-spanning forms that are activated by their extracellular ligands: ANF receptors (left) in cells of the renal collecting ducts and the smooth muscle of blood vessels and guanylin receptors (right) in intestinal epitethelial cells. The guanylin receptor is also the target of a bacterial endotoxin that triggers severe diarrhea.

    (b) NO receptor
         The second type is a soluble enzyme that is activated by intracelluar NO; this form is found in many tissues, including smooth muscle of the heart and blood vessels.

 

 

 

 

 

 

 

 

ANF = atrial natriuretic factor

NO = nitric oxide


Signaling from activated G protein-linked receptors
 


    (a) cAMP pathway
    , involving stimulatory G protein
         (
    Gs)

cAMP pathway (Gs)¸¦ ±×¸²À¸·Î ¼³¸íÇÑ´Ù. (A)

cAMP

Gs = stimulatory G protein

PKA = cAMP-dependent protein kinase


 

    (b) IP3 pathway
        (Phospholipase C (
    PLC¥â) pathway).     Binding of a ligand to a seven transmembrane receptor activates a G protein, which in turn activates phospholipase C. This enzyme then cleaves phosphatidylinositol 4,5-triphosphate (IP3) and 1,2-diacylglycerol (DAG). DAG activates protein kinase C, which phosphorylates a series of proteins altering cell function. The IP3 diffuses through the cytoplasm and interacts with membrane channels in the endoplasmic reticulum, causing release of calcium ions and cellular responses.

IP3 pathway (PLC¥â)¸¦ ±×¸²À¸·Î ¼³¸íÇÑ´Ù. (A)

PLC¥â
    Phospholipase C¥â,     activated by G
    protein

PKC Ca++-dependent
    protein kinase



Activation of glucocorticoid receptors

 





  * Estrogen antagonist: Tamoxifen
    Progesterone antagonist: RU486

Ç×¾ÏÁ¦ tamoxifen°ú »çÈÄ ÇÇÀÓÁ¦ RU486ÀÇ ¾à¸®±âÀüÀ» ¼³¸íÇÑ´Ù. (A)

 

Cell Cycle and Regulation of Cell Division
 

 <Cell Cycle and Cyclins>

    : Cdk-cyclin complexes

Cell cycleÀ» ±×¸²À¸·Î ¼³¸íÇϰí À̸¦ Á¦¾îÇÏ´Â ÀÎÀÚµéÀ» ±â¼úÇÑ´Ù. (B)

 

 

Cell cycleÀ» Á¶ÀýÇÏ´Â moleculeµéÀ» ¾î¶»°Ô ¹ß°ßÇßÀ»±î?, ¾î¶»°Ô À̸§ Áö¾úÀ»±î ¢Ñ

 

Growth Factors
 

 <Classification>

    1. Growth stimulators (Growth factors)

´ëÇ¥ÀûÀÎ growth factorµé°ú À̵éÀÇ ¿ªÇÒÀ» ±â¼úÇÑ´Ù. (B)

         = Competence factors: Rendering the cells
             competent to do DNA synthesis

         = Progression factors: Stimulating DNA
             synthesis in competent cells

Growth factor¿Í oncgene°úÀÇ °ü°è  ¢Ñ

     2. Growth inhibitors

          : Transforming growth factor ¥â
            Tumor necrosis factor
            Interferon ¥â

     3. Factors for cell locomotion, contractility, and differentiation

  <Some Important Growth Factors>

      - Epidermal growth factor (EGF)

         : Proliferation of epithelial cells and fibroblasts
         : EGF-EGFR tyrosine kinase (c-erb B1) ¡æ
           Phosphorylation ¡æ
           RNA and DNA synthesis

        Transforming growth factor alpha (TGF¥á)

          : Homology to EGF

      - Platelet-derived growth factor (PDGF)

          : Platelets (¥á granules)
            Macrophages, endothelial cells, smooth muscle cells,
            tumor cells
          : Migration and proliferation of fibroblasts,
            smooth muscles, and monocytes
          : PDGF-PDGFR tyrosine kinase

      - Fibroblast growth factor (FGF)

          = Acidic FGF (aFGF, FGF-1)
          = Basic FGF (bFGF, FGF-2): Angiogenesis

          : Multifunctional
          : FGF-FGFR tyrosine kinase

      - Vascular endothelial growth factor (VEGF) = Vascular permeability factor

          : Vasculogenesis
            Angiogenesis 

      - Transforming growth factor beta (TGF¥â)

          : Platelets, endothelial cells, lymphocytes, macrophages
          : Growth inhibitor/stimulator
            Fibrogenesis
            Deactivation of macrophages
          : Serine-threonine kinase receptor 

      - Cytokines - IL-1 and TNF

          : Fibrosis and remodelling of connective tissue

EXTRACELLULAR MATRIX AND CELL-MATRIX INTERACTIONS
 

* EXTRACELLULAR MATRIX

Extracellular matrixÀÇ ±¸¼º¼ººÐÀ» ¿­°ÅÇÑ´Ù. (A)

 


 

     - Structural fibrous proteins

         = Collagen: Strengthened organization
         = Elastin: Resilience

     - Adhesive glycoproteins

         = Fibronectin
             : Heterodimer
               Mesenchymal cell-matrix attachment via integrin and RGD
         = Laminin
             : Heterotrimer, cross-shaped
               Epithelial cell-basal lamina attachemnt
         = Nonfibrillar collagen
         = Thrombospondins
         = Tenascin

     - Polysaccharides and proteoglycans (Ground substances)
 

        = Glycosaminoglycans (Mucopolysaccharides)

            : Hyaluronic acid (hyaluronan)

glycan polysaccharide


         = Proteoglycans (Mucoproteins)

             : Core protein + Glycosaminoglycans
                                - Chondroitin sulfate,
                                  dermatan sulfate
                                - Heparan sulfate, heparin
                                - Keratan sulfate
 

 <Organization of ECM>

Extracellular matrixÀÇ organizationÀ» ¿­°ÅÇÑ´Ù. (A)

     - Interstitial matrix

     - Basement membrane

         = Type IV collagen
         = Fibronectin
         = Laminin
         = Proteoglycans
         =
Others
 

monomer

dimer

 

meshwork


          Basement Membrane - Type IV Collagen 

 

 <Cell-Matrix Interactions>

Cell°ú Extracellular matrixÀÇ interactionÀ» ¿­°ÅÇÑ´Ù. (A)

     - Integrins

         : Integrins on cell ¡ê RGD of Fibronectin, laminin, collagen in ECM,
           
forming focal adhesion complexes and providing tensegrity
         :
Cell proliferation, differentiation, locomotion

     - Cell surface proteoglycans

         = Syndecan ¡ê Fibronectin, collagen, thrombospondin in ECM

     - Matricellular proteins

         : Secreted adaptor proteins between cells and ECM
         =
SPARC (secreted protein acidic and rich in cysteine) (= Osteonectin)
         =
Osteopontin
         = Thrombospondins
         =
Tenascin

 


Schematic illustration of the sequence of events in the invasion of epithelial basement membranes by tumors (A-C). Tumor cells attach to the basement membrane via the laminin receptors and secrete proteolytic enzymes, including type IV collagenase and plasminogen activator. Degradation of the basement menbranes and tumor cell migration follow.